Moreover, exDNA serves as a ligand for pattern recognition receptors (PRRs) such as Toll-like receptor 9 (TLR9), activating downstream signaling pathways that can support cancer progression by inducing pro-inflammatory cytokines and enhancing tumor-promoting inflammation [150]. This evidence concerns the gene TLR9 and cancer.